Pierre Sauvanet

Clermont-ferrand, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Minimally invasive pancreatectomy with mesentericoportal venous resection: Results from a French national cohort.

Minimally invasive pancreatectomy with mesentericoportal venous resection: Results from a French national cohort.

Journal: HPB : the official journal of the International Hepato Pancreato Biliary Association

Published: September 09, 2025

Cytotoxic Necrotizing Factor 1-producing E. coli Enhance Colorectal Tumorigenesis in ApcMin/+ Mice With Autophagy Deficiency in Intestinal Epithelial Cells.

Cytotoxic Necrotizing Factor 1-producing E. coli Enhance Colorectal Tumorigenesis in ApcMin/+ Mice With Autophagy Deficiency in Intestinal Epithelial Cells.

Journal: The Journal of infectious diseases

Published: August 09, 2025

ATG16L1 in myeloid cells limits colorectal tumor growth in ApcMin/+ mice infected with colibactin-producing Escherichia coli via decreasing inflammasome activation.

ATG16L1 in myeloid cells limits colorectal tumor growth in ApcMin/+ mice infected with colibactin-producing Escherichia coli via decreasing inflammasome activation.

Journal: Autophagy

Published: May 31, 2024

The colibactin-producing Escherichia coli alters the tumor microenvironment to immunosuppressive lipid overload facilitating colorectal cancer progression and chemoresistance.

The colibactin-producing Escherichia coli alters the tumor microenvironment to immunosuppressive lipid overload facilitating colorectal cancer progression and chemoresistance.

Journal: Gut microbes

Published: February 28, 2024

Colibactin-producing Escherichia coli enhance resistance to chemotherapeutic drugs by promoting epithelial to mesenchymal transition and cancer stem cell emergence.

Colibactin-producing Escherichia coli enhance resistance to chemotherapeutic drugs by promoting epithelial to mesenchymal transition and cancer stem cell emergence.

Journal: Gut microbes

Published: February 20, 2024

Epigenetic master regulators HDAC1 and HDAC5 control pathobiont Enterobacteria colonization in ileal mucosa of Crohn's disease patients.

Epigenetic master regulators HDAC1 and HDAC5 control pathobiont Enterobacteria colonization in ileal mucosa of Crohn's disease patients.

Journal: Gut microbes

Published: September 29, 2022

Role of adherent and invasive Escherichia coli in Crohn's disease: lessons from the postoperative recurrence model.

Role of adherent and invasive Escherichia coli in Crohn's disease: lessons from the postoperative recurrence model.

Journal: Gut

Published: August 24, 2021

When idiopathic male infertility is rooted in maternal malnutrition during the perinatal period in mice†.

When idiopathic male infertility is rooted in maternal malnutrition during the perinatal period in mice†.

Journal: Biology of reproduction

Published: July 22, 2021

Anti-TNF Agents Restrict Adherent-invasive Escherichia coli Replication Within Macrophages Through Modulation of Chitinase 3-like 1 in Patients with Crohn's Disease.

Anti-TNF Agents Restrict Adherent-invasive Escherichia coli Replication Within Macrophages Through Modulation of Chitinase 3-like 1 in Patients with Crohn's Disease.

Journal: Journal of Crohn's & colitis

Published: July 18, 2021

Colibactin-Producing Escherichia coli Induce the Formation of Invasive Carcinomas in a Chronic Inflammation-Associated Mouse Model.

Colibactin-Producing Escherichia coli Induce the Formation of Invasive Carcinomas in a Chronic Inflammation-Associated Mouse Model.

Journal: Cancers

Published: April 12, 2021

Beneficial Effects of Natural Mineral Waters on Intestinal Inflammation and the Mucosa-Associated Microbiota.

Beneficial Effects of Natural Mineral Waters on Intestinal Inflammation and the Mucosa-Associated Microbiota.

Journal: International journal of molecular sciences

Published: March 17, 2021

Prognostic value of a combination of innovative factors (gut microbiota, sarcopenia, obesity, metabolic syndrome) to predict surgical/oncologic outcomes following surgery for sporadic colorectal cancer: a prospective cohort study protocol (METABIOTE).

Prognostic value of a combination of innovative factors (gut microbiota, sarcopenia, obesity, metabolic syndrome) to predict surgical/oncologic outcomes following surgery for sporadic colorectal cancer: a prospective cohort study protocol (METABIOTE).

Journal: BMJ open

Published: January 10, 2020

Showing 1-12 of 25

Last Updated: 09/26/2026